DRKS00003496已完成不适用
Basic immunization against TBE in persons over fifty years with FSME-IMMUN Adults - PRIMER
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 411
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50 Years 至 one（—）
- 性别
- All
入选标准
- •All patients 50 years and older who receive the basic immunization with FSME-IMMUN Adults can be considered for the target population.
- •The patients must not have received any TBE vaccination in the past and must not have ever been infected with TBE. They must have given their written consent to participate in this noninterventional study.
排除标准
- •no exclusion criteria
研究者
相似试验
进行中（未招募）
1 期
Primary TBE vaccination for the elderlyImmune response to TBE vaccinationEUCTR2019-002541-37-SERegion Örebro län90
进行中（未招募）
不适用
Vaccination against TBE in patients who use immunosuppressive drugsTBE vaccin in patients using immunosuppressive drugsMedDRA version: 12.1Level: LLTClassification code 10046859Term: VaccinationMedDRA version: 12.1Level: LLTClassification code 10037153Term: PsoriasisMedDRA version: 12.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisMedDRA version: 12.1Level: LLTClassification code 10054980Term: Immunosuppressant drug therapyEUCTR2010-019438-28-SEMälarsjukhuset Eskilstuna
尚未招募
4 期
Primary TBE Vaccination for the ElderlyVaccineTick-borne EncephalitisNCT04573205Region Örebro County90
已完成
4 期
TBE (Tick-borne Encephalitis) Vaccination in Allergic PatientsVaccine Responsiveness in AllergyVaccine Responsiveness During Allergy De-sensitization TreatmentNCT02511535Medical University of Vienna119
已完成
4 期
Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and AdultsTick Born EncephalitisNCT00387634Novartis Vaccines323